The research compound in Victoza®
Victoza® is a type 2 diabetes medicine from Novo Nordisk. Its active compound is Liraglutide — which is what this catalogue supplies, as a research material.
This is not Victoza®, and NOVALYTE LABS has no affiliation with Novo Nordisk. We supply the compound Liraglutide for laboratory research only — not for human consumption, diagnostic, therapeutic or veterinary use. Victoza® is a trademark of Novo Nordisk, referenced here only to identify the compound.
Victoza is the brand under which liraglutide is marketed for type 2 diabetes. The same compound is sold as Saxenda for weight management.
It was among the first GLP-1 agonists engineered for extended action through fatty-acid acylation, a design principle later taken further by semaglutide.
The compound is listed here as a research material, not as the branded medicine.
Liraglutide in this catalogue
0.6mg × 5 pens
How Liraglutide is supplied here
Everything below describes the research material in this catalogue, not the medicine. Liraglutide is stocked in 3 presentations, so the figures below are for the base one.
| Compound | Liraglutide |
|---|---|
| Presentation | 0.6mg × 5 pens |
| Dosage options | 0.6mg × 5 pens · 1.8mg × 5 pens · 3mg × 5 pens |
| Research category | Metabolic Research |
| Batch COA | Certificate supplied with order |
| Availability | In stock |
| Intended use | Laboratory research only — not for human or veterinary use |
Common questions
What is the active compound in Victoza?
Liraglutide. Victoza is a registered trademark of Novo Nordisk, approved for type 2 diabetes.
Is this Victoza?
No. NOVALYTE LABS supplies Liraglutide as a research material with batch documentation. It is not Victoza, it is not a medicine, it is not supplied for human use, and there is no affiliation with Novo Nordisk.
Why is Liraglutide sold under more than one brand?
Because a brand is tied to an approved indication rather than to the molecule. Liraglutide is marketed as Victoza and also as Saxenda — same compound, different approvals.
Other brands using Liraglutide
The same compound is marketed under more than one brand, usually because each brand carries a different approved indication.